Find a Research Expert

Experts
 Menu

Catherine Godson

Institution

University College Dublin

Contact

Subjects

Biochemistry

Details
Publications 93
As first author 3
As last author 37
Unique topics 597
Collaborations 72
Patents 1
Sources 6
Are you Catherine Godson? Click here to provide feedback on your profile.
All
2018
2017
2016
2015
2014
2013
2012
2011
2010
Earlier
All
2018
2017
2016
2015
2014
2013
2012
2011
2010
Earlier

2018

Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A
2018

Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications
2017

AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin
2017

BMP7-induced-Pten inhibits Akt and prevents renal fibrosis
2017

Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease.
2017

Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis.
2017

Specialized pro-resolving mediators in renal fibrosis.
2017

Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes
2016

AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin.
2016

NR4A Receptors Differentially Regulate NF-κB Signaling in Myeloid Cells.
2016

Protective Effect of let-7 miRNA Family in Regulating Inflammation in Diabetes-Associated Atherosclerosis.
2016

REST is a hypoxia-responsive transcriptional repressor.
2016

Wnt6 regulates epithelial cell differentiation and is dysregulated in renal fibrosis.
2015

Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease.
2015

Mesenchymal stem cells deliver exogenous microRNA let7c via exosomes to attenuate renal fibrosis.
2015

Specialised lipid mediators and their targets.
2014

BMP signalling: agony and antagony in the family.
2014

Hypoxia-sensitive pathways in inflammation-driven fibrosis.
2014

IHG-1 increases mitochondrial fusion and bioenergetic function.
2014

Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease.
2014

Paricalcitol protects against TGF-β1-induced fibrotic responses in hypoxia and stabilises HIF-α in renal epithelia.
2014

Targeting cellular drivers and counter-regulators of hyperglycaemia- and transforming growth factor-β1-associated profibrotic responses in diabetic kidney disease.
2013

Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1.
2013

TGFβ and CCN2/CTGF mediate actin related gene expression by differential E2F1/CREB activation.
2013

The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation.
2013

The genetics of diabetic nephropathy.
2012

CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFβ type II receptor with implications for nephropathic cell phenotypes.
2012

Connective tissue growth factor antagonizes transforming growth factor-?1/Smad signalling in renal mesangial cells
2012

IHG-1 amplifies TGF-β1 signalling and mitochondrial biogenesis and is increased in diabetic kidney disease.
2012

IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responses.
2012

Lipoxin A4 attenuates adipose inflammation.
2012

Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications.
2011

Connective tissue growth factor antagonizes transforming growth factor-β1/Smad signalling in renal mesangial cells.
2011

Deletion of Gremlin1 increases cell proliferation and migration responses in mouse embryonic fibroblasts.
2011

Fibrinogen as a damage-associated mitogenic signal for the renal fibroblast.
2011

Lipoxin A₄ and benzo-lipoxin A₄ attenuate experimental renal fibrosis.
2011

Macrophages in synovial inflammation.
2011

Next-generation sequencing identifies TGF-β1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy.
2010

Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model.
2010

CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: implications for the pathogenesis of diabetic nephropathy.
2010

FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
2010

Jagged/Notch signalling is required for a subset of TGFβ1 responses in human kidney epithelial cells.
2010

Lipoxins : regulators of resolution
2010

Molecular circuits of resolution in renal disease.
2010

Synthesis and biological evaluation of pyridine-containing lipoxin A4 analogues.
2009

Allelic depletion of grem1 attenuates diabetic kidney disease.
2009

Diabetes mellitus and apoptosis: inflammatory cells.
2009

Extracellular BMP-antagonist regulation in development and disease: tied up in knots.
2009

Lipoxin A4 inhibits IL-1beta-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells.
2009

Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells.
2009

Lipoxins: resolutionary road.
2008

IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosis.
2008

Lipoxins: update and impact of endogenous pro-resolution lipid mediators.
2008

Protein kinase B/Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition in vitro and in vivo.
2008

Regulation and consequences of differential gene expression in diabetic kidney disease.
2007

Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages.
2007

Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities.
2007

Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesis.
2007

The Lipoxin A4 receptor is coupled to SHP-2 activation: implications for regulation of receptor tyrosine kinases.
2006

Connective tissue growth factor/CCN2 stimulates actin disassembly through Akt/protein kinase B-mediated phosphorylation and cytoplasmic translocation of p27(Kip-1).
2006

Lipoxin A4 redistributes myosin IIA and Cdc42 in macrophages: implications for phagocytosis of apoptotic leukocytes.
2006

Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.
2005

Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy.
2005

Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells.
2005

Microarray and bioinformatic detection of novel and established genes expressed in experimental anti-Thy1 nephritis.
2005

Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26).
2005

Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor.
2005

Taking insult from injury: lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells.
2004

Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization.
2004

Lipoxins: endogenous regulators of inflammation.
2003

DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transition.
2003

Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarrays.
2003

Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog.
2003

The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia.
2002

15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure.
2002

Biphasic regulation of leukocyte trafficking by lipoxins.
2002

Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation.
2002

Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases.
2002

Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo.
2002

The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells.
2001

Lipoxins: revelations on resolution.
2000

Gremlins, glomeruli and diabetic nephropathy.
2000

IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1.
2000

Influence of lipoxin A(4) and other lipoxygenase-derived eicosanoids on tissue factor expression.
2000

Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors.
2000

Lipoxins: novel anti-inflammatory therapeutics?
1999

Regulation of leukocyte trafficking by lipoxins.
1999

Serum from hemodialysis patients inhibits basal and cytokine-stimulated tissue factor expression in vitro.
1999

Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells.
1998

Leukotrienes and lipoxins: lipoxygenase-derived modulators of leukocyte recruitment and vascular tone in glomerulonephritis.
1998

Protein kinases C: potential targets for intervention in diabetic nephropathy.
1988

Acute hypomagnesaemia complicating the treatment of meconium ileus equivalent in cystic fibrosis.
1988

Investigation of aminoglycoside nephrotoxicity in cystic fibrosis patients.

These arethe6 unique sources for Catherine Godson's 93 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.

Source #
Ireland -> Dublin City University 1
Ireland -> Dublin City University -> PubMed 1
Ireland -> Trinity College Dublin 4
Ireland -> Trinity College Dublin -> PubMed 3
Ireland -> University College Dublin 89
Ireland -> University College Dublin -> PubMed 83
Dec 2, 2010

FIBROSUPPRESSANT BIOTHERAPEUTICS
+

  1. Further insights

    Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.

  2. Details

    Here is a quick breakdown of this expert's publication history

  3. Contact

    If this is the expert you have been looking for, simply click here to make contact.